TCL Archive Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research December 15, 1995
TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs. October 31, 2003
TCL Archive Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin January 16, 2009